Joint Bookrunner
€ 45 million
Rights Issue
- Valneva aquired Crucell Sweden and DUKORAL from J&J to complement their portfolio of traveler's vaccines
- The €45m fully underwritten rights issue allows for certainty of funds at time of signing
- Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner